| 注册
首页|期刊导航|世界中医药|养心开郁片治疗中、轻度抑郁症90例临床观察

养心开郁片治疗中、轻度抑郁症90例临床观察

林海 王静怡 王晓燕 王开娜 刘岗 吕富荣 杨琳 查鹏洲

世界中医药2011,Vol.6Issue(3):201-203,3.
世界中医药2011,Vol.6Issue(3):201-203,3.

养心开郁片治疗中、轻度抑郁症90例临床观察

Observation of Efficacy of Yangxin Kaiyu Tablets on 90 Patients with Moderate or mild Depression

林海 1王静怡 2王晓燕 1王开娜 1刘岗 1吕富荣 1杨琳 1查鹏洲1

作者信息

  • 1. 西安市中医医院,西安市西华门2号,710003
  • 2. 陕西省中医医院
  • 折叠

摘要

Abstract

Objectives:To observe efficacy and safety of Yangxin Kaiyu tablets on moderate or mild depression. Method: 135 patients were randomized to the tablet arm ( n =90, 4 tablets, 3 times per day ) and Fluoxetine arm ( n =45, 25mg/day in the morning ); background medication: 4 Zaoan capsules 30min before bed. Efficacy and safety parameters include the Hamilton depression rating scale ( HAMD-17 ), TCM syndrom scale, Symptom Checklist 90 ( SCL-90 ), self-rating scale for depression ( SDS ), self-rating scale for Anxiety ( SAS ), Rating Scale for Side Effects( SERS ) and related laboratory analysis at WEEK2 and WEEK6. Results: There were no statistical significance of before treatment ( P > 0.05 ). At WEEK2 both groups improved on all parameters ( P < 0.05 ); At WEEK6 total effective rate for the tablet was 85.55%. The total effective rate and the scores of various rating scale at the set time points were not statistically different between the two groups. The SAS assessment was better with the tablet. Palpitation, insomnia and the symptom of depression improved significantly in the treatment group and the control group respectively ( P < 0.05 ). No safety concerns revealed during the study. Conclusion: the Yangxin Kaiyu tablets can treat moderate or mild depression without obvious safety issue.

关键词

抑郁症/中医药疗法/养心开郁片

引用本文复制引用

林海,王静怡,王晓燕,王开娜,刘岗,吕富荣,杨琳,查鹏洲..养心开郁片治疗中、轻度抑郁症90例临床观察[J].世界中医药,2011,6(3):201-203,3.

基金项目

陕西省科技厅项目(2008 k10-01) (2008 k10-01)

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文